Clinical Trial

Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies

Study acronym: AROM-HEMATO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 12, 2024 (before its estimated December 16, 2025 completion). Its status may not reflect the trial's current state.
Summary
This project will optimise the management of chemotherapy-induced nausea and vomiting, with improvements in nausea and vomiting scores, quality of life and appetite expected in participants benefiting from the intervention. In all cases, the use of complementary methods is recommended and improves the management of people with cancer because they offer a person-centred approach.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-20; most recent amendment 2024-12-09.
Status change: Not Yet Recruiting → Recruiting 2024-05-21
Trial Details
NCT Number NCT06150469
Lead Sponsor University Hospital, Limoges
Conditions Hematological Malignancies
Enrollment 286 participants
Start Date 2024-04-17
Primary Completion 2025-12-16 (estimated)
Study Completion 2026-12-16 (estimated)
Updated on ClinicalTrials.gov 2024-12-12